Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Pediatrics|May 1, 1988
Biochemical abnormalities in rhizomelic chondrodysplasia punctataG Hoefler, S Hoefler, P A Watkins, et al.
Neurology|July 1, 1988
Neonatal seizures and retardation in a girl with biochemical features of X-linked adrenoleukodystrophy: a possible new peroxisomal disease entityS Naidu, G Hoefler, P A Watkins, et al.
American Journal of Human Genetics|January 23, 1999
Peroxisomal bifunctional protein deficiency revisited: resolution of its true enzymatic and molecular basisE G van Grunsven, E van Berkel, P A Mooijer, et al.
British Journal of Cancer|November 9, 2013
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patientsJ Szkandera, M Stotz, G Absenger, et al.
British Journal of Cancer|February 8, 2014
MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patientsM Pichler, A L Ress, E Winter, et al.
British Journal of Cancer|June 27, 2013
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancerM Stotz, A Gerger, F Eisner, et al.
Oncogene|November 25, 2014
A stress-induced early innate response causes multidrug tolerance in melanomaD Ravindran Menon, S Das, C Krepler, et al.
Oncogene|January 27, 2015
A stress-induced early innate response causes multidrug tolerance in melanomaD Ravindran Menon, S Das, C Krepler, et al.
Oncogene|July 4, 2012
Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasmsM Eißmann, I M Melzer, S B M Fernández, et al.
Virchows Archiv : an International Journal of Pathology|September 20, 2008
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance programJ H J M van Krieken, A Jung, T Kirchner, et al.
Pageof 6